600833 第一医药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)13.8889.14216.6686.5329.340
总资产报酬率 ROA (%)7.7704.5768.5113.6195.247
投入资产回报率 ROIC (%)10.2886.09811.6145.2227.891

边际利润分析
销售毛利率 (%)16.71519.10120.52517.73717.786
营业利润率 (%)11.2245.4387.1782.5134.505
息税前利润/营业总收入 (%)13.3896.1537.1993.3104.672
净利润/营业总收入 (%)10.7654.9075.4053.5344.319

收益指标分析
经营活动净收益/利润总额(%)0.81723.417118.75746.75671.608
价值变动净收益/利润总额(%)5.53720.3082.3132.9762.129
营业外收支净额/利润总额(%)20.78915.791-0.05946.13821.135

偿债能力分析
流动比率 (X)1.7321.6511.5081.4921.472
速动比率 (X)1.1771.1601.1471.0091.111
资产负债率 (%)41.48845.87452.98541.70546.334
带息债务/全部投入资本 (%)12.78214.96428.2555.10217.660
股东权益/带息债务 (%)593.286482.544218.5471,623.254437.043
股东权益/负债合计 (%)139.971117.16788.083138.520114.742
利息保障倍数 (X)-17.147-20.157277.658-2.442-4.487

营运能力分析
应收账款周转天数 (天)50.76047.48525.18234.03328.107
存货周转天数 (天)80.89881.56346.83867.30060.196